Article ; Online: Hydroxychloroquine as prophylaxis or treatment for COVID-19
Indian Journal of Public Health, Vol 64, Iss 6, Pp 125-
What does the evidence say?
2020 Volume 127
Abstract: Hydroxychloroquine (HCQ), an antimalarial has been proposed as possible treatment for coronavirus disease-2019 (COVID-19). India has approved the use of HCQ for prophylaxis of asymptomatic health workers treating suspected or confirmed COVID-19 cases, ... ...
Abstract | Hydroxychloroquine (HCQ), an antimalarial has been proposed as possible treatment for coronavirus disease-2019 (COVID-19). India has approved the use of HCQ for prophylaxis of asymptomatic health workers treating suspected or confirmed COVID-19 cases, and asymptomatic household contacts of confirmed patients. The U.S. Food and Drug Administration has issued Emergency Use Authorization for the use of HCQ to treat COVID-19 in adolescents and adults. In this review, we go over the available evidence for and against HCQ's use as prophylaxis or treatment for COVID-19, especially in the Indian context. |
---|---|
Keywords | chloroquine ; covid-19 ; hydroxychloroquine ; prophylaxis ; Public aspects of medicine ; RA1-1270 ; covid19 |
Language | English |
Publishing date | 2020-01-01T00:00:00Z |
Publisher | Wolters Kluwer Medknow Publications |
Document type | Article ; Online |
Database | BASE - Bielefeld Academic Search Engine (life sciences selection) |
Full text online
More links
Kategorien
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.